Visão geral da empresa Refocus Group
Fabricação de produtos farmacêuticosIndústria
At Refocus Group, our mission is to become the surgical standard of care for presbyopia. To achieve this end, we are committed to advancing the research and development of treatments that will meet the needs of patients and eye care professionals currently unmet by other treatment options.
Refocus Group’s latest breakthrough is the VisAbility™ Micro-Insert System, an investigational medical device used in an innovative procedure called the VisAbility Procedure. VisAbility works to uniquely restore near vision for patients with presbyopia without affecting their ability to see in the distance, so patients can See Young Again.
Refocus Group’s latest breakthrough is the VisAbility™ Micro-Insert System, an investigational medical device used in an innovative procedure called the VisAbility Procedure. VisAbility works to uniquely restore near vision for patients with presbyopia without affecting their ability to see in the distance, so patients can See Young Again.
Refocus Group, Inc. is a medical device company involved in researching and developing innovative treatments for human vision disorders, particularly for the treatment of presbyopia. Our VisAbility™ Micro-Insert System—the world’s first binocular presbyopic treatment that works outside the visual axis—is currently in clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.